MADRIGAL PHARMACEUTICALS INC
MDGL·558868105·US·equity·Healthcare - Biotechnology-Activist
MDGL (MADRIGAL PHARMACEUTICALS INC) is held by 186 institutional investors as of Q1 2026. Largest holders: BAKER BROS. ADVISORS LP ($1.1B), JANUS HENDERSON GROUP PLC ($1.1B), RTW INVESTMENTS, LP ($1B). Net institutional sentiment: Mixed.
186
Holders
Avg rating(18 Elite)
$9.8B
Total Value
48% (201)
Fund Consensus
91 buying - 98 selling
Smart Money Verdict44Weak MomentumStrong Convergence
Get 5 free verdicts/month - sign up in 10 seconds
See how MDGL's score breaks down across 4 SEC sources
Held by 186 funds
18 elite
Who's Trading
13F: Insider & Congress:
Fund | Action | Shares | Value | Weight | Est. P&L | Conviction |
|---|---|---|---|---|---|---|
Unchanged | 2.1M | $1.1B | 6.4% | +214.73% | 0 | |
Increased | 2M(+27.4%) | $1.1B | 0.5% | +124.25% | 56 | |
Unchanged | 2M | $1B | 10.4% | +97.35% | 0 | |
Increased | 1.8M(+0.6%) | $951.8M | 9.4% | +229.84% | 63 | |
Decreased | 1.6M(-5.2%) | $816.6M | 0.0% | +56.16% | 0 | |
Increased | 694,958(+50.6%) | $363.8M | 0.1% | +17.32% | 43 | |
Increased | 609,525(+4.5%) | $319.1M | 0.0% | +115.32% | 32 | |
Increased | 511,728(+16.5%) | $267.9M | 0.0% | +50.44% | 36 | |
Increased | 455,870(+0.9%) | $238.7M | 0.0% | +174.50% | 31 | |
Increased | 453,843(+1156.0%) | $237.6M | 0.0% | +25.93% | 50 | |
Decreased | 340,519(-3.9%) | $178.3M | 0.6% | +58.09% | 0 | |
Decreased | 329,519(-9.8%) | $172.5M | 0.0% | +37.39% | 0 | |
Increased | 289,310(+7.1%) | $151.4M | 0.5% | +61.46% | 46 | |
Decreased | 277,371(-9.3%) | $145.2M | 0.0% | +38.38% | 0 | |
Increased | 249,511(+0.8%) | $130.6M | 1.3% | +61.05% | 48 | |
Increased | 225,510(+78.4%) | $118M | 0.2% | +12.48% | 55 | |
Decreased | 216,720(-1.1%) | $113.4M | 0.0% | +113.78% | 0 | |
Increased | 191,294(+27.1%) | $100.1M | 0.0% | +62.27% | 37 | |
Decreased | 189,527(-54.4%) | $99.2M | 0.0% | +23.46% | 0 | |
Increased | 187,240(+2.9%) | $97.9M | 0.1% | +131.33% | 37 |
